Main Topic: A San Francisco-based biotech company called Loyal, in partnership with Crynetics, has developed a medication that aims to extend the lifespan of large breed dogs. The company has cleared a key FDA hurdle and is planning a larger trial to test the drug's efficacy.
Key Points:
Participants:
Takeaways:
Noel King
The dog arm of a San Francisco-based biotech firm called Cellular Longevity says it's developed a new medication that'll help large breed dogs live longer.
Emily Mullen
Loyal, that's the name of the dog arm, partnered with the pharma company Crynetics to develop the medication, which should be on the market very soon.
Noel King
If your first reaction is, that's fantastic, followed by, sorry, dog arm, Crynetics, you're in good company. Scientists may be googly-eyed over this new medication, but animal ethicists are on edge.
Emily Mullen
Well, I'm not saying I necessarily think it's wrong. I mean, you asked me if I would do it. Yes, you're right. You're an ethicist, and it's good for you to draw that distinction.
Noel King
Yeah. Coming up on Today Explained, long live your dog.
Sound effects: Upbeat music starts playing
Announcer (Voiceover)
Support for this show comes from ServiceNow. AI is only as powerful as the platform it's built into, don't you know? That's why it's no surprise that more than 85% of the Fortune 500 use the ServiceNow AI platform.
Noel King
I'm Noelle King. Emily Mullen is a staff writer at Wired Magazine. She covers biotechnology and she's a dog person.
Emily Mullen
I do not have a dog, but my parents do. He is a very sweet English cream golden retriever who's sort of lazy and does his own thing, but we love him.
Noel King
I have a lot of adjectives to describe my pug, and sweet is not one of them, but I love him so much.
Emily Mullen
Emily recently wrote for Wired about a company called Loyal, which made some very big news. This San Francisco biotech company has just cleared a key FDA hurdle on the path to getting a drug approved to extend the lifespan of dogs.
Noel King
So they haven't gotten approval yet. There are still a couple more steps in that process. But this is sort of the first major step.
Emily Mullen
Based on initial data the company has submitted to the FDA, The agency has basically said this drug has a reasonable expectation of success.
Noel King
And that's kind of a big deal for the FDA to do because it has never approved a drug for life extension, for longevity, for animals or humans.
Emily Mullen
So this is kind of a sign that the FDA is ready to take this idea seriously. How far back? I mean, listen, I think a lot about medicines for humans and the advances that have been made since time immemorial, right?
Noel King
How long have scientists been studying life lengthening drugs for dogs?
Emily Mullen
Well, scientists have been interested in this general idea of life extension for a long time. In the 1980s and 90s, they identified the first genes that modulate lifespan, and they did this in worms first.
Noel King
And since then, there have been studies in different lab animals, rodents, fruit flies, more worms.
Emily Mullen
And scientists have shown that certain genes seem to be key regulators of lifespan in these animals.
Noel King
The genes that control dog size and specifically make big dogs live a shorter life is all connected to one of the most well-understood and OG longevity pathways there is because the first time they showed was a single gene mutation that they could make a worm live longer.
Emily Mullen
They made that worm genetically like a chihuahua.
Noel King
So Loyal with this drug is specifically trying to lengthen the lifespan of large and giant breed dogs.
Emily Mullen
And there's this well-known inverse relationship between dog size and how long they live.
Noel King
So you probably know that Great Danes, Irish Wolfhounds, Bernese Mountain Dogs, these dogs only live six, seven, eight years.
Emily Mullen
And yet the smallest of the dogs that humans have bred, chihuahuas, for example, can live up to 20 years.
Noel King
And so there's this inverse relationship here.
Emily Mullen
And scientists have pinpointed one potential driver, a hormone called IGF-1, that seems to be present in high levels in these large dogs and in low levels in small dogs.
Noel King
And of course, humans have been breeding dogs for hundreds of years for certain characteristics.
Emily Mullen
And that has resulted in this big disparity in dog size that we don't really see in many other mammals.
Noel King
I mean, purebreds are very inbred and in fact, several studies have shown that mixed breed dogs on average live longer than purebred dogs.
Emily Mullen
Basically, when people were breeding for size, Our thesis is that they accidentally gave dogs an accelerated aging disease, basically the things that control the dog growing really quickly in puberty don't fully turn off.
Noel King
Then the dog ages at a faster rate and dies sooner.
Emily Mullen
Okay, so big dogs have higher levels of a hormone called IGF-1, and they die more quickly than smaller dogs.
Noel King
What does IGF-1 do, and is it fair to say it's killing large dogs more quickly?
Emily Mullen
Well one explanation for why large dogs have shorter lives than small dogs is that maybe they aging at a faster rate IGF has been linked to growth and bone size and it plays a role in metabolism
Noel King
So what Loyal is trying to do is reduce levels of this hormone throughout the body of these large dogs.
Emily Mullen
And they say that in initial studies of a little over 100 dogs, that they have been able to bring this level down to what is seen in medium-sized dogs.
Noel King
So we're not talking about getting rid of this hormone completely or bringing it down to levels in small dogs.
Emily Mullen
But Loyal says that at least in the initial studies it's done, that it can actually do this in large dogs and bring this hormone to levels seen in medium-sized dogs.
Noel King
Would it affect their bone growth and their metabolism?
Emily Mullen
So with this drug, Loyal aims to treat dogs that are at least seven years old.
Noel King
The company hasn't really said how this drug is going to affect dogs' health at that age.
Emily Mullen
We don't really know exactly the mechanisms behind how it's working.
Noel King
And the company has kept some of that information close.
Emily Mullen
So we don't exactly know yet.
Noel King
And right now, the company is planning a bigger trial of around 1,000 dogs that's going to start either next year or in 2025 to do this bigger efficacy study.
Emily Mullen
What's going to happen is they'll have a placebo group and an experimental group.
Noel King
And of course, some dogs won't receive the drug, will receive a placebo. Some dogs will.
Emily Mullen
They're enrolling people's pets in this trial.
Noel King
So if you have a large or giant breed dog out there, you know, you might be able to get your dog enrolled in this trial.
Emily Mullen
God, I wish I could get my pug enrolled in this trial. I want him to live forever.
Noel King
How do dogs receive this treatment?
Emily Mullen
I mean, is this something where you have to take them to a hospital to get it done, or is this as simple as, you know, it's a pill you grind up over their food?
Noel King
So for now, this drug is an injection designed to be given in a veterinarian's office every three to six months.
Emily Mullen
For the company to get conditional approval of this drug from the FDA, the company has already shown that there's a reasonable expectation of effectiveness, but it still has to conduct this larger study.
Noel King
It also has to show the FDA that this drug is safe for dogs and it has to show that the drug can be manufactured safely and reliably.
Emily Mullen
Once it does that, the company can then ask the FDA to conditionally approve this drug.
Noel King
And a conditional approval is essentially a temporary approval, which is going to allow Loyal to market the drug for up to five years.
Emily Mullen
And at that point, at that five years, the conditional approval is going to expire.
Noel King
So Loyal is going to have to show in this large trial of around a thousand dogs that it does work or else it has to take the drug off the market.
Emily Mullen
But if it does have this great data showing it does, in fact, extend the life of these large dogs, then the drug will be fully approved by the FDA.
Noel King
Are there any side effects of this medication?
Emily Mullen
Well, we don't really know yet because Loyola has said it has tested this drug so far in about 130 research dogs.
Noel King
But at least in the initial tests of this drug, they didn't see any major cause for concern.
Emily Mullen
A couple of dogs had runny stools for a couple of days after treatment, but nothing serious.
Noel King
But again, that's what this bigger trial is for.
Sound effects: Upbeat music continues
Announcer (Voiceover)
Support for today's show comes from Adio. What is Adio?
Emily Mullen
Adio is an AI-native customer relationship management system built specifically for the next era of companies.
Announcer (Voiceover)
They say it's extremely powerful, adapts to your unique data structures and scales with any business model.
Emily Mullen
According to Adio Adio takes less than a minute to set up
Announcer (Voiceover)
And within seconds you will have your email and calendars synced
Emily Mullen
You see all your relationships in a fully fledged platform, they say, all enriched with that actionable data.
Announcer (Voiceover)
And they say you can build AI-powered automations and use its research agent to tackle some of your most complex processes to seize so that you can focus on what matters, building your company.
Emily Mullen
You can join industry leaders such as Flatfile, Replicate, Modal, and so much more.
Announcer (Voiceover)
You can go to attio.com slash todayexplained to get 15% off your first year.
Noel King
Dogs are naturally good and loyal and kind. Huh, that's true.
Sound effects: Upbeat music continues
Today Explained, we're back with Rebecca Walker. She's a professor of social medicine and philosophy at UNC Chapel Hill.
Rebecca Walker
She focuses on animal research and ethics.
Noel King
And that includes our relationship with what she calls companion animals.
Rebecca Walker
I think the word companion animal can be confusing for people.
Noel King
So I just mean by that pets.
Rebecca Walker
I think people are really too focused on their own interests in their relationship with the animal and not thinking enough about what life is like from their point of view.
Noel King
For instance, Professor Rebecca?
Rebecca Walker
Well, I mean, I don't know if I should say this, but I think giving your pet drugs to extend their life by a little bit just so you can spend a little bit more time with them would be a prime example of that kind of problematic attitude because I think it's probably not in the best interest of the animal.
Noel King
Rebecca has a cat, a few chickens, a golden retriever named Pepper.
Rebecca Walker
So I asked her, would she give this loyal drug to Pepper?
Noel King
No, certainly not this drug at this time.
Rebecca Walker
But generally, I think probably not.
Noel King
Medications all have risks and side effects.
Rebecca Walker
She's a perfectly healthy dog. She's not in a position to communicate with me how she's feeling about any drugs that I might be giving her other than, you know, her behavior or her sort of, you know, medical signs that aren't necessarily going to track, you know, how she's actually feeling.
Noel King
So, you know, why would I give her a drug that could harm her and at best expand her life for a few months?
Rebecca Walker
I think that might be in my interest, but I doubt it's in her interest.
Noel King
Let's dig into that a little bit more, that last thing you said about it's in my interest but not necessarily in her interest.
Rebecca Walker
So among the distinctions that I want you to kind of just spin out a little bit are if a dog is sick, we give them medication.
Noel King
What's the difference between a dog is sick and so we give him or her medication and a dog eventually is going to die and now there's this drug that can make them live longer?
Rebecca Walker
The things I would be concerned about is amongst them.
Noel King
I think when we're behaving for the sake of other people and we're doing actions that are primarily with respect to thinking about their interests, it's important that we don't confuse what we want with what they really have an interest in.
Rebecca Walker
And so I think for, you know, a human being who maybe they have a big project that they're working on or something that they've been sort of trying to get finished their whole life and, you know, they just need a couple more months of life to get it done.
Noel King
Maybe for them, this would make sense because it would give meaning to their life as a whole.
Rebecca Walker
But dog lives aren't like that.
Noel King
They're sort of really driven by their day-to-day welfare and not by those kind of big projects.
Rebecca Walker
So I think you need to think about the dog life from her point of view and what's good for her.
Noel King
And is it worth the risk of having some unpleasant experiences or unpleasant reactions just to sort of add a little bit more life from her point of view?
Rebecca Walker
I think for us, because they live a lot less than we live.
Noel King
We think of their short lives as, you know, tragically short.
Rebecca Walker
But from her point of view, things are quite different.
Noel King
So I think if she was experiencing an illness or suffering from a disease or disability, that would be a really different situation because then it would be in her interest to give her a medication.
Rebecca Walker
Even in that case, it often happens that people may treat animals or extend their lives beyond what is actually in their interest because they just can't let them go.
Noel King
All right. So we have this company make this announcement.
And so we understand that people who own or guard or live with large dogs will soon be able to make this decision for themselves.
Rebecca Walker
From an ethical standpoint, what should people consider before they think about giving a medication like this to their pets?
Noel King
So I think there are a few different things.
Rebecca Walker
One, I think this issue about whether an animal is a healthy animal or a sick animal is really important.
Noel King
And so you really need to do a risk-benefit sort of analysis on their behalf.
Rebecca Walker
Which, again, I think is really difficult for us to do because our interests are all kind of caught up in wanting them to live longer and thinking about sort of the benefit they provide to us by being part of our lives.
Noel King
So I think it's really important for people to, as much as they can, to remove themselves from that equation and try to think about things from the point of view of the animal.
Rebecca Walker
But also in that regard, I think one thing for people to be aware of up front is that when this drug hits the market if it does so under this FDA conditional approval it won actually have been proven effective to extend an animal healthy lifespan
Noel King
And the sort of rhetoric around it sounds really positive and people are obviously hopeful that it will be effective.
Rebecca Walker
Scientists could be on the brink of a big breakthrough when it comes to helping four-legged friends live longer.
Noel King
Giving you possibly an extra year of cuddles, fetch, and slobbery kisses.
Rebecca Walker
But it does mean that veterinarians can be prescribing it and owners can be thinking they're doing something that's going to help their pet live longer, but it's not actually necessarily the case.
Noel King
So whether it actually works will depend on getting the full results of the clinical trials that are still going to be ongoing at the point that it's approved.
Rebecca Walker
We heard in the first half of the show that this type of drug could someday be available to humans.
Noel King
Now, you've drawn this distinction, which is my dog, as much as I love him, is never going to retire and start learning another language and travel and develop hobbies.
Rebecca Walker
Ghoulie is always just going to have walks and treats, and that's about it.
Noel King
But human life can be really fulfilling past a certain point.
Rebecca Walker
Do you think life-extending drugs for humans are something that is ethically interesting, tricky, dubious?
Noel King
I'm not... worried about it just because it's life expanding.
Rebecca Walker
I mean, typically in bioethics, we make a distinction between medical interventions that treat or prevent disease or disability and those that enhance us in some way.
Noel King
And I think that the way that the people who are promoting this drug have been talking about it, they've been talking about it as a kind of prevention.
Rebecca Walker
In particular, it's preventing death.
Noel King
One of the cool things, at least how we're trying to approach it, is that we're looking at preventative medicine.
Rebecca Walker
And specifically, one way to think about it is statins.
Noel King
A large portion of the adult U.S. population is on statins to reduce their risk of future cardiac events.
Rebecca Walker
That's what I think an aging drug should be.
Noel King
But it's pretty clear that it falls into the enhancement category in terms of that distinction.
Rebecca Walker
So we're trying to add more life to a normal lifespan.
Noel King
And I'm not that worried about that because what's normal in terms of our lifespan has, you know, changed dramatically over the centuries and in result to environmental shifts and, you know, even just plain old sanitation.
Rebecca Walker
So I guess what I'm more concerned about is lifespan is already really closely associated with wealth.
Noel King
Yeah.
Rebecca Walker
And these drugs might be expensive and might give better off people even more access to longer life.
Noel King
So there's a certain fairness issue and access issue that I think would be really important to consider.
Rebecca Walker
I also think that, you know, we're sort of always looking for a kind of fountain of youth or a way to expand and extend our lives instead of recognizing the reality that we are all going to die.
Noel King
And the importance of doing the best we can with what we have.
Rebecca Walker
And I just sort of feel like this is kind of one more way of adding to that problematic perspective.
Noel King
It sounds like your point of view is that we should think maybe a bit less about extending the lives of our pets and think more about improving the quality of the lives of our pets.
Rebecca Walker
How should we do that other than the obvious?
Noel King
Yeah, well, I think one important thing we can think about is how animals are bred for human interests.
Rebecca Walker
And I was saying before, I'm more concerned with how we're already relating to animals.
Noel King
So just for example, take my golden retriever, right?
Rebecca Walker
There's some evidence that their lifespans have been going down as they've been bred more intensively to have particular kinds of looks.
Noel King
You know, we should think first about how we're creating animal breeds and lines in ways that already diminish their lifespan before we think about taking the lifespan that we've already shortened and lengthening it by adding a drug into the mix.
Rebecca Walker
So I think that that's kind of more what I'd be interested in us looking at.
Sound effects: Upbeat music continues
Noel King
Today's show was produced by Amanda Llewellyn.
Amanda Llewellyn
She has a little brother dog. His name is Opie.
Noel King
It was edited by Matthew Collette, Orzo's dad.
Matthew Collette
It was fact-checked by Laura Bullard, mom of Murph and Muzzy.
Laura Bullard
And it was engineered by David Herman, who is a cat person, whatever that means.
David Herman
Hey, Robocop and Smalls.
Noel King
This is Today Explained, and it's the second time this year we've put our pets' names in the credits.
One more thing before we go.
We're working on an episode about millennials dreading motherhood.
Are you a millennial?
I know that a lot of you are.
If you were born between 1981-ish and 1996-ish and you're feeling some type of way about becoming a parent, please give us a call and tell us about why that is.
Our number is 202-643-0314.
Keep your message brief, please, and we might use it in the show.
Heads up. 202-643-0314.
Sound effects: Upbeat music continues
Announcer (Voiceover)
With real fruit, organic agave, and Himalayan pink salt, every sip is like a mini getaway.
No fillers, no hangovers.
Find your flavor at senoritadrinks.com.
Use code VOX20 for 20% off.
Must be 21+.
This product may cause intoxication.
This product has not been evaluated or approved by the FDA.
This product may contain up to 0.3% THC.